going intracellular, page-79

In saying that and the quarterlies do all show $0 receipts for last year with the exception of January 13's extension however the half yearly report last month says $700K has been invoiced revenue for January / March 2014 ? So is this the expansion payment highlighted in July that so far hasn't been seen 9 months later ?

"The Company’s cash position after completion of the entitlement issue on 8th January 2013 was $6.2 million, with $0.7 million of invoiced revenue to be received January/ March 2014 and approximately $1.8 million from the R&D tax offset in September 2014. Expenditure is presently running at the rate of $0.45 million per month which annualises to $5.4 million.